Treating Drug-resistant Tuberculosis Infection: No More Excuses

Clin Infect Dis. 2021 May 18;72(10):1716-1718. doi: 10.1093/cid/ciaa328.
No abstract available

Keywords: Pakistan; fluoroquinolones; resistance; safety; suffering.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents